The present invention is directed to a method for expression of at least one heterologous gene in a host cell comprising transforming a host cell with at least one nucleic acid construct comprising a complete subunit of an RNA polymerase or a portion thereof of a hybrid nucleic acid containing a portion of the subunit of an RNA polymerase obtained from the same genus as the heterologous gene, and transforming the host cell, with at least one heterologous gene; and culturing the transformed host cell. The present invention further is directed to nucleic acid molecules used in the present method, vectors containing these nucleic acid molecules, and host cells containing the nucleic acid molecules. The nucleic acid encoding the subunit of an Agrobacterium RNA polymerase and the corresponding amino acid sequence and portions thereof is disclosed.
Method Of Detecting Disease Conditions In Infected With Animal Virus
Marie Chow - Little Rock AR, US Courtney Wilkins - Little Rock AR, US Khaled Machaca - Little Rock AR, US
Assignee:
Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
C12Q 1/70 A61K 39/12
US Classification:
435 5, 4242041
Abstract:
The present invention provides methods for studying pathogenesis of mammalian viruses. In particular, the present invention provides a nonhuman animal model system for studying disease mechanism wherein the nonhuman animal model is infected with an animal virus. In a preferred embodiment, the animal model is and the animal virus is vesicular stomatitis virus (VSV).
Development Of A Simple Animal Model For Infection By Viruses And Other Obligate Intracellular Parasites
Marie Chow - Little Rock AR, US Courtney Wilkins - Little Rock AR, US Khaled Machaca - Little Rock AR, US
Assignee:
Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
A61K 39/12
US Classification:
800 13, 800 21, 4242041
Abstract:
The present invention provides methods for studying pathogenesis of mammalian viruses. In particular, the present invention provides a nonhuman animal model system for studying disease mechanisms wherein the nonhuman animal model is infected with an animal virus. In a preferred embodiment the animal model is and the animal virus is vesicular stomatitis virus (VSV).
Smadar Cohen - Petach-Tickya, IL Carmen Bano - 46020 Valencia, ES Karyn B. Visscher - State College PA Marie B. Chow - Brookline MA Harry R. Allcock - State College PA Robert S. Langer - Newton MA
International Classification:
B01J 1302
US Classification:
42840222
Abstract:
A method for encapsulating biologically-labile materials such as proteins, liposomes, bacteria and eucaryotic cells within a synthetic polymeric capsule, and the product thereof, are disclosed. The method is based on the use of a water-soluble polymer with charged side chains that are crosslinked with multivalent ions of the opposite charge to form a gel encapsulating biological material, that is optionally further stabilized by interactions with multivalent polyions of the same charge as those used to form the gel. In the preferred embodiment, hydrolytically stable polyphosphazenes are formed of monomers having carboxylic acid side groups that are crosslinked by divalent or trivalent cations such as Ca. sup. 2+ or Al. sup. 3+, then stabilized with a polycation such as poly-L-lysine. A variety of different compositions can be formed from the crosslinked polymer.
Smadar Cohen - Petach-Tickva, IL Carmen Bano - Valencia, ES Karyn B. Visscher - State College PA Marie Chow - Brookline MA Harry R. Allcock - State College PA Robert S. Langer - Newton MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA Pennsylvania Research Corporation - University Park PA
International Classification:
A61K 950
US Classification:
424499
Abstract:
A method for encapsulating biologically-labile materials such as proteins, liposomes, bacteria and eucaryotic cells within a synthetic polymeric capsule, and the product thereof, are disclosed. The method is based on the use of a water-soluble polymer with charged side chains that are crosslinked with multivalent ions of the opposite charge to form a gel encapsulating biological material, that is optionally further stabilized by interactions with multivalent polyions of the same charge as those used to form the gel. In the preferred embodiment, hydrolytically stable polyphosphazenes are formed of monomers having carboxylic acid side groups that are crosslinked by divalent or trivalent cations such as Ca. sup. 2+ or Al. sup. 3+, then stabilized with a polycation such as poly-L-lysine. A variety of different compositions can be formed from the crosslinked polymer.
Production Of Neutralizing Antibodies By Polypeptide Vp1 Of Enteroviruses And By Oligopeptide Fragments Of Polypeptide Vp1
David Baltimore - Cambridge MA Marie B. Chow - Cambridge MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 3900
US Classification:
424 86
Abstract:
The production of neutralizing antibodies for poliovirus, or other enteroviruses, are disclosed herein employing the capsid polypeptide VP1. Vaccines can be produced employing this polypeptide in place of killed or live attenuated virus, and the VP1 polypeptide can be employed in assays in place of whole virions. VP1 polypeptide can be produced by isolating it from live virion or can be produced by cloning cDNA sequences coding for this protein in recombinant cDNA vectors.
Brent Dorval - Leominster MA Marie Chow - Brookline MA Alexander Klibanov - Newton MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 3913
US Classification:
4242171
Abstract:
Non-lyophilized vaccine compositions which contain a poliovirus and, as stabilizer, a compound containing at least two amino or imine groups. The stabilizers include polyimines such as the amino acid lysine or ethylenediamine and polyimines such as poly(ethylenimine).
Smadar Cohen - Petach-Tickya, IL Carmen Bano - Valencia, ES Karyn B. Visscher - State College PA Marie Chow - Brookline MA Harry R. Allcock - State College PA Robert S. Langer - Newton MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA The Penn State Research Foundation - University Park PA
International Classification:
B01J 1302 A61K 950
US Classification:
424489
Abstract:
A method for encapsulating biologically-labile materials such as proteins, liposomes, bacteria and eucaryotic cells within a synthetic polymeric capsule, and the product thereof, are disclosed. The method is based on the use of a water-soluble polymer with charged side chains that are crosslinked with multivalent ions of the opposite charge to form a gel encapsulating biological material, that is optionally further stabilized by interactions with multivalent polyions of the same charge as those used to form the gel. In the preferred embodiment, hydrolytically stable polyphosphazenes are formed of monomers having carboxylic acid side groups that are crosslinked by divalent or trivalent cations such as Ca. sup. 2+ or Al. sup. 3+, then stabilized with a polycation such as poly-L-lysine. A variety of different compositions can be formed from the crosslinked polymer.
Name / Title
Company / Classification
Phones & Addresses
Marie Chow Phd Full
University of Arkansas for Medical Sciences Hospital & Health Care · College/University · Anesthesiology · Oncology · Ent · Endocrinologist · Surgeons · Emergency Medicine
4501 W Markham, Little Rock, AR 72205 4301 W Markham, Little Rock, AR 72205 4301 W Markham Slot, Little Rock, AR 72205 (501)6867000, (501)6617962, (501)6868496, (501)6868365